The model performed well in assessing treatment responses, but experts explained that one of the most beneficial aspects of their model was that its results are interpretable in a “clinician-friendly way.” 

The study touts the benefits of targeted radionuclide alpha therapy for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) who have not had success with other treatments.

Men with prostate cancer can avoid many of the unpleasant side effects of chemo, surgery and radiation therapy when they are treated with high-intensity focused ultrasound instead.

Salvage radiation therapy guidelines for patients with prostate cancer recurrence need to be updated to include findings identified on PSMA PET, according to new research shared at SNMMI’s annual conference this week. 

The Detroit-based cancer institute achieved this landmark moment using the MRIdian A3i, which is the latest enhancement of the MRIdian system from ViewRay, Inc.

The mandatory bundled payment initiative was slated to kick off Jan. 1, 2023, following numerous delays, but will now launch on a to-be-determined date.

The team originally planned to enroll 300 men in the study, but the decisive results seen among the first 100 patients prompted them to cut enrollment in half.

Scans using a smaller dose were accurate when detecting lesions 0.5 cm or larger but more research into low-contrast lesions is still necessary, experts cautioned.